Approved Hospital Formulary
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

umeclidinium

umeclidinium
Brand names: Incruse Ellipta
Form Strength
POWDER, INHALATION 62.5 mcg (0.0625 mg)/inh


Additional Information:

Non-Formulary agent. All orders will be automatically changed to Tiotropium (SPIRIVA Respimat). See Therapeutic Interchange.


Last updated: Mar. 24, 2022







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.